US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 5.010
- -0.570-10.22%
Close Nov 4 16:00 ET
- 5.010
- 0.0000.00%
Post 20:01 ET
5.25MMarket Cap-68P/E (TTM)
5.700High5.000Low29.93KVolume5.550Open5.580Pre Close160.62KTurnover5.03%Turnover RatioLossP/E (Static)1.05MShares40.80052wk High2.09P/B2.98MFloat Cap2.08052wk Low--Dividend TTM595.21KShs Float899.526Historical High--Div YieldTTM12.55%Amplitude2.080Historical Low5.366Avg Price1Lot Size
Portage Biotech Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 51.17%-1.69M | -18.42%-14.3M | 33.33%-3.12M | -26.89%-3.43M | -70.86%-4.29M | -58.69%-3.45M | -78.49%-12.07M | -107.95%-4.68M | -63.09%-2.7M | -97.02%-2.51M |
| Net income from continuing operations | 71.92%-1.66M | 27.98%-75.38M | 73.62%-24.91M | -424.97%-39.38M | -376.04%-5.17M | -264.68%-5.93M | -446.02%-104.67M | -965.72%-94.46M | -78.34%-7.5M | 62.29%-1.09M |
| Operating gains losses | -2,384.00%-1.14M | -3,568.08%-7.39M | -94,528.57%-6.62M | -912.38%-853K | -28.57%40K | -15.25%50K | 126.96%213K | 98.36%-7K | 229.63%105K | 30.23%56K |
| Depreciation and amortization | -27.27%8K | 5,300.00%54K | --13K | 1,400.00%15K | --15K | --11K | --1K | --0 | --1K | --0 |
| Deferred tax | --0 | 40.92%-10.56M | --0 | -536.83%-9.5M | 64.16%-915K | 94.20%-148K | -506.94%-17.88M | -409.03%-14.95M | 2,264.13%2.18M | -288.58%-2.55M |
| Other non cash items | ---- | -182.59%-7.32M | -121.26%-6.88M | -425.19%-1.72M | 432.50%133K | 3,703.33%1.14M | -2,259.17%-2.59M | -10,463.33%-3.11M | 1,660.00%528K | -233.33%-40K |
| Change In working capital | 48.92%968K | 9,920.00%982K | 77.74%-313K | -127.35%-212K | 845.22%857K | -11.68%650K | 97.83%-10K | -164.29%-1.41M | 96.70%775K | -387.50%-115K |
| -Change in receivables | ---- | ---- | ---- | -106.25%-4K | ---- | ---- | ---- | ---- | -84.98%64K | -97.13%5K |
| -Change in prepaid assets | 1,297.01%802K | 97.40%-32K | 60.36%-348K | 165.86%218K | -57.14%165K | 83.58%-67K | -240.48%-1.23M | -114.67%-878K | -177.34%-331K | -17.03%385K |
| -Change in payables and accrued expense | -82.37%128K | -12.75%972K | 131.96%178K | -143.17%-430K | 197.08%498K | -38.89%726K | 191.91%1.11M | -303.28%-557K | 387.86%996K | 13.93%-513K |
| -Change in other current assets | 480.00%38K | 66.67%40K | --39K | -83.33%4K | --7K | ---10K | 114.55%24K | --0 | 116.90%24K | --0 |
| -Change in other working capital | ---- | -97.62%2K | ---- | ---- | ---- | --1K | 115.38%84K | 500.00%54K | -21.43%22K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 51.17%-1.69M | -18.42%-14.3M | 33.33%-3.12M | -26.89%-3.43M | -70.86%-4.29M | -58.69%-3.45M | -78.49%-12.07M | -107.95%-4.68M | -63.09%-2.7M | -97.02%-2.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 555.75%2.81M | 2.81M | 0 | -617K | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | ---3K | --0 | --0 | ---- |
| Net investment purchase and sale | ---- | --2.81M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---614K | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | 555.75%2.81M | --2.81M | --0 | ---- | ---- | ---617K | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -101.32%-8K | 5,200.85%5.97M | -100.19%-4K | 591.82%5.33M | 101.30%39K | 606K | -100.43%-117K | 2.12M | 770K | -3,614.81%-3.01M |
| Net issuance payments of debt | -28.57%-9K | 98.00%-40K | ---12K | ---11K | 99.50%-10K | ---7K | ---2M | --0 | --0 | ---2M |
| Net common stock issuance | --0 | 102.15%6.03M | 144.33%5.35M | --0 | --50K | --632K | -89.75%2.98M | --2.19M | --794K | --0 |
| Proceeds from stock option exercised by employees | --1K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | 98.18%-20K | -7,987.88%-5.34M | 22,341.67%5.34M | ---1K | ---19K | 40.66%-1.1M | ---66K | ---24K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -101.32%-8K | 5,200.85%5.97M | -100.19%-4K | 591.82%5.33M | 101.30%39K | --606K | -100.43%-117K | --2.12M | --770K | -3,614.81%-3.01M |
| Net cash flow | ||||||||||
| Beginning cash position | -52.32%5.03M | -54.84%10.55M | -59.24%5.34M | -77.09%3.45M | -63.65%7.7M | -54.84%10.55M | 743.03%23.35M | -48.82%13.1M | -44.84%15.04M | -26.00%21.18M |
| Current changes in cash | 40.50%-1.69M | 56.92%-5.52M | 87.77%-313K | 198.04%1.9M | 30.71%-4.25M | -30.84%-2.85M | -162.22%-12.81M | -13.68%-2.56M | -16.65%-1.93M | -352.65%-6.14M |
| End cash Position | -56.69%3.33M | -52.32%5.03M | -52.32%5.03M | -59.24%5.34M | -77.09%3.45M | -63.65%7.7M | -54.84%10.55M | -54.84%10.55M | -48.82%13.1M | -44.84%15.04M |
| Free cash flow | 51.17%-1.69M | -18.39%-14.3M | 33.33%-3.12M | -26.89%-3.43M | -70.66%-4.29M | -58.69%-3.45M | -78.53%-12.08M | -107.95%-4.68M | -63.09%-2.7M | -97.25%-2.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data